Cargando…

A broad and potent neutralization epitope in SARS-related coronaviruses

Mostrar otras versiones (1)

Many neutralizing antibodies (nAbs) elicited to ancestral SARS-CoV-2 through natural infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants. Here we show therapeutic antibody ADG20 is able to neutralize all SARS-CoV-2 variants of concern (VOCs) including Omicron (B.1.1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Meng, Zhu, Xueyong, He, Wan-ting, Zhou, Panpan, Kaku, Chengzi I., Capozzola, Tazio, Zhu, Connie Y., Yu, Xinye, Liu, Hejun, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Peng, Linghang, Song, Ge, Cottrell, Christopher A., Schief, William R., Nemazee, David, Walker, Laura M., Andrabi, Raiees, Burton, Dennis R., Wilson, Ian A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936108/ https://www.ncbi.nlm.nih.gov/pubmed/35313576 http://dx.doi.org/10.1101/2022.03.13.484037

Ejemplares similares

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

IBCL-054 The Effects of an mRNA COVID-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans
por: Frankel, Arthur, et al.
Publicado: (2022)

Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
por: Song, Ge, et al.
Publicado: (2023)

The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans
por: Frankel, Arthur E., et al.
Publicado: (2022)

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
por: Zhou, Panpan, et al.
Publicado: (2023)

Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron
por: Liu, Hejun, et al.
Publicado: (2022)

Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes
por: Hurtado, Jonathan, et al.
Publicado: (2023)

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease
por: Zhou, Panpan, et al.
Publicado: (2022)

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2022)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2023)

Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses
por: He, Wan-ting, et al.
Publicado: (2022)

Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
por: He, Wan-ting, et al.
Publicado: (2022)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2022)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2023)

A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
por: Zhou, Panpan, et al.
Publicado: (2022)

A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
por: Zhou, Panpan, et al.
Publicado: (2022)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

Structural basis of a shared antibody response to SARS-CoV-2
por: Yuan, Meng, et al.
Publicado: (2020)

Structural basis of a public antibody response to SARS-CoV-2
por: Yuan, Meng, et al.
Publicado: (2020)

Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India
por: Andrabi, Raiees, et al.
Publicado: (2012)

An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
por: Rappazzo, C. Garrett, et al.
Publicado: (2020)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
por: Rappazzo, C. Garrett, et al.
Publicado: (2021)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
por: Zhu, Xueyong, et al.
Publicado: (2022)

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
por: Zhao, Fangzhu, et al.
Publicado: (2022)

Cross clade reactive plasma anti-V3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time
por: Andrabi, Raiees, et al.
Publicado: (2012)

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor
por: Andrabi, Raiees, et al.
Publicado: (2013)

A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
por: Lee, Jeong Hyun, et al.
Publicado: (2017)

Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity
por: Goldberg, Benjamin S., et al.
Publicado: (2021)

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
por: Wu, Nicholas C., et al.
Publicado: (2020)

Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
por: Song, Ge, et al.
Publicado: (2020)

Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
por: Song, Ge, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

Epitope-Analyzer: A structure-based webtool to analyze broadly neutralizing epitopes
por: Montiel-Garcia, Daniel, et al.
Publicado: (2022)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Broad epitope coverage of a human in vitro antibody library
por: Sivasubramanian, Arvind, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aa46qbjak65375r96ps9tddcjh